Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bartholini

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effectsH Depoortere, B Zivkovic, K G Lloyd, et al.
Advances in Neurology|January 1, 1974
L-DOPA: chemical modifications and biological evaluationA Brossi, W Pool, H Sheppard, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
Journal of Medicinal Chemistry|June 1, 1980
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramideJ P Kaplan, B M Raizon, M Desarmenien, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
Histological and molecular biochemistryN E Andén, G Bartholini, H Corrodi, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effectsH Depoortere, B Zivkovic, K G Lloyd, et al.
Advances in Neurology|January 1, 1974
L-DOPA: chemical modifications and biological evaluationA Brossi, W Pool, H Sheppard, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
Journal of Medicinal Chemistry|June 1, 1980
New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramideJ P Kaplan, B M Raizon, M Desarmenien, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
Histological and molecular biochemistryN E Andén, G Bartholini, H Corrodi, et al.
Pageof 10